Bio-Rad Laboratories (BIO-B) Inventory Average (2010 - 2026)

Bio-Rad Laboratories (BIO-B) has 17 years of Inventory Average data on file, last reported at $755.6 million in Q1 2026.

• Quarterly Inventory Average fell 2.51% year-over-year to $755.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $755.6 million (down 2.51% YoY) and the FY2025 annual result came in at $750.4 million, down 2.58% from the prior year.
• Inventory Average fell to $755.6 million in Q1 2026 per BIO-B's latest filing, from $761.9 million in the prior quarter.
• Across five years, Inventory Average topped out at $804.0 million in Q3 2024 and bottomed at $588.9 million in Q1 2022.
• The 5-year median for Inventory Average is $775.0 million (2025), against an average of $746.4 million.
• The widest annual swing landed in 2022, when Inventory Average dropped 4.05%; it then rose 25.01% in 2023.
• Tracing BIO-B's Inventory Average over 5 years: stood at $702.6 million in 2022, then rose by 10.75% to $778.2 million in 2023, then climbed by 0.51% to $782.1 million in 2024, then decreased by 2.58% to $761.9 million in 2025, then decreased by 0.83% to $755.6 million in 2026.
• Per Business Quant, the three latest BIO-B Inventory Average figures stand at $755.6 million (Q1 2026), $761.9 million (Q4 2025), and $791.0 million (Q3 2025).

Peer Comparison